Dr. Corey Westerfeld Specializes in Retina, Vitreous & Diabetic Eye Disease

The latest technology for retinal surgery is being offered at the Greater New Bedford Surgicenter.  According to Dr. Corey Westerfeld, a vitreoretinal surgeon at EHVC, this new technology has been of great benefit for patients undergoing many types of retinal procedures.  The new instrumentation for vitrectomy surgery enters through tiny incisions, one half the size of those used previously.  In fact, the incisions are so small that they are often self-sealing and do not require sutures.  The instruments are much smaller than their predecessors, allowing more precision in handling the delicate tissues inside the eye.  “Recent advances in vitreoretinal surgery have allowed intraocular surgery to be performed in a manner that is safer and faster than before,” says Dr. Westerfeld.  “Newer techniques have allowed for improved efficiency while at the same time improving outcomes.”  Dr. Westerfeld states that he is “committed to delivering the latest technologies in retinal surgery to my patients at EHVC.” 

Small-incision retinal surgery is now being used at EHVC to correct a variety of retinal problems.  Retinal conditions amenable to this treatment include macular pucker (scar tissue on the retina), macular holes (holes in the retina), retinal detachments, and problems relating to diabetic eye disease, among others.  “Retinal diseases remain one of the more difficult to treat problems in the eye but with the latest technologies and improved techniques, we are delivering the best available treatment to our patients at EHVC and our results are excellent,” says Dr. Westerfeld.

The new technology has tremendous benefits for the patients having these procedures.  Since there is less tissue manipulation and significantly less operating time, the eyes recover faster from the surgery and with fewer complications.  There is also much less post-operative discomfort.  Dr. Westerfeld states, “I am pleased with our results using small-incision surgery, and I look forward to continuing my goal of restoring sight in our patients at EHVC.”